Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Pharma Industry News Lilly selects Lehigh Valley, Pennsylvania for obesity drug manufacturing plant Lilly is building a $3.5B injectable medicine facility in Pennsylvania to scale retatrutide. Find out how this reshapes the obesity drug market and U.S. supply. bySrinathFebruary 2, 2026